Literature DB >> 2523631

Sulfated glycosaminoglycans in amyloid plaques of prion diseases.

A D Snow1, R Kisilevsky, J Willmer, S B Prusiner, S J DeArmond.   

Abstract

Brain sections from cases of human Creutzfeldt-Jakob disease, Gerstmann-Sträussler syndrome, kuru, and hamster scrapie containing amyloid were examined for the presence of sulfated glycosaminoglycans (GAGs), the anionic component of proteoglycans, using the sulfated Alcian blue method and Alcian blue technique with 0.3 M and 0.7 M magnesium chloride. These studies suggest that sulfated glycosaminoglycans are part of the CNS amyloid plaques in each of the above human prion disorders as well as in experimental scrapie. All the amyloid plaques stained positively with Alcian blue at 0.3 M, and less so at 0.7 M magnesium chloride indicating the presence of sulfated GAGs. Therefore, the amyloid plaques of prion diseases possess similar histochemical features to those found in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523631     DOI: 10.1007/bf00687367

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  36 in total

1.  DEGENERATION OF THE CEREBELLAR AND HYPOTHALAMONEUROHYPOPHYSIAL SYSTEMS IN SHEEP WITH SCRAPIE; AND ITS RELATIONSHIP TO HUMAN SYSTEM DEGENERATIONS.

Authors:  E BECK; P M DANIEL; H B PARRY
Journal:  Brain       Date:  1964-03       Impact factor: 13.501

2.  Infectious etiology of neuritic (senile) plaques in mice.

Authors:  H M Wiśniewski; M E Bruce; H Fraser
Journal:  Science       Date:  1975-12-12       Impact factor: 47.728

3.  Differential staining of acid glycosaminoglycans (mucopolysaccharides) by alcian blue in salt solutions.

Authors:  J E Scott; J Dorling
Journal:  Histochemie       Date:  1965-10-01

4.  Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity.

Authors:  N Kitaguchi; Y Takahashi; Y Tokushima; S Shiojiri; H Ito
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

5.  Identification of a protein that purifies with the scrapie prion.

Authors:  D C Bolton; M P McKinley; S B Prusiner
Journal:  Science       Date:  1982-12-24       Impact factor: 47.728

6.  Changes in the localization of brain prion proteins during scrapie infection.

Authors:  S J DeArmond; W C Mobley; D L DeMott; R A Barry; J H Beckstead; S B Prusiner
Journal:  Neurology       Date:  1987-08       Impact factor: 9.910

7.  Characterization of tissue and plasma glycosaminoglycans during experimental AA amyloidosis and acute inflammation. Qualitative and quantitative analysis.

Authors:  A D Snow; R Kisilevsky; C Stephens; T Anastassiades
Journal:  Lab Invest       Date:  1987-06       Impact factor: 5.662

8.  Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related.

Authors:  C W Wong; V Quaranta; G G Glenner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  Sulfated glycosaminoglycans in Alzheimer's disease.

Authors:  A D Snow; J P Willmer; R Kisilevsky
Journal:  Hum Pathol       Date:  1987-05       Impact factor: 3.466

10.  Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.

Authors:  C L Masters; G Multhaup; G Simms; J Pottgiesser; R N Martins; K Beyreuther
Journal:  EMBO J       Date:  1985-11       Impact factor: 11.598

View more
  35 in total

1.  Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.

Authors:  M Horiuchi; B Caughey
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.

Authors:  C Wong; L W Xiong; M Horiuchi; L Raymond; K Wehrly; B Chesebro; B Caughey
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

Review 3.  Molecular interactions of amyloid nanofibrils with biological aggregation modifiers: implications for cytotoxicity mechanisms and biomaterial design.

Authors:  Durga Dharmadana; Nicholas P Reynolds; Charlotte E Conn; Céline Valéry
Journal:  Interface Focus       Date:  2017-06-16       Impact factor: 3.906

4.  Diffuse deposition of immunohistochemically labeled prion protein in the granular layer of the cerebellum in a patient with Creutzfeldt-Jakob disease.

Authors:  H A Kretzschmar; T Kitamoto; J Doerr-Schott; P Mehraein; J Tateishi
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

5.  Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis.

Authors:  M P McKinley; R K Meyer; L Kenaga; F Rahbar; R Cotter; A Serban; S B Prusiner
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

Review 6.  Sulfated glycosaminoglycans in protein aggregation diseases.

Authors:  Kazuchika Nishitsuji; Kenji Uchimura
Journal:  Glycoconj J       Date:  2017-04-11       Impact factor: 2.916

7.  A simplified recipe for prions.

Authors:  Kil Sun Lee; Byron Caughey
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

8.  Electrostatic Complementarity Drives Amyloid/Nucleic Acid Co-Assembly.

Authors:  Allisandra K Rha; Dibyendu Das; Olga Taran; Yonggang Ke; Anil K Mehta; David G Lynn
Journal:  Angew Chem Int Ed Engl       Date:  2019-11-14       Impact factor: 15.336

9.  Ligand binding promotes prion protein aggregation--role of the octapeptide repeats.

Authors:  Shuiliang Yu; Shaoman Yin; Nancy Pham; Poki Wong; Shin-Chung Kang; Robert B Petersen; Chaoyang Li; Man-Sun Sy
Journal:  FEBS J       Date:  2008-11       Impact factor: 5.542

10.  Ultrastructural neuropathology of chronic wasting disease in captive mule deer.

Authors:  D C Guiroy; E S Williams; P P Liberski; I Wakayama; D C Gajdusek
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.